Analysis of Yersinia pseudotuberculosis Isolates Recovered from Deceased Mammals of a German Zoo Animal Collection

von Hammerl, J. A., vom Ort, N., Barac, A., Jäckel, C., Grund, L., Dreyer, S., Heydel, C., Kuczka, A., Peters, H., Hertwig, S.
Veröffentlicht in J Clin Microbiol (2021)

Risk of cardiovascular adverse events from trastuzumab (Herceptin(®)) in elderly persons with breast cancer: a population-based study

von Tsai, H.-T., Isaacs, C., Fu, A. Z., Warren, J. L., Freedman, A. N., Barac, A., Huang, C.-Y., Potosky, A. L.
Veröffentlicht 2014

Cardiometabolic Risk Factors and Survival after Breast Cancer in the Women’s Health Initiative

von Simon, MS, Beebe Dimmer, JL, Hastert, TA, Manson, JE, Cespedes Feliciano, EM, Neuhouser, ML, Ho, GYF, Freudenheim, JL, Strickler, H, Ruterbusch, J, Barac, A, Chlebowski, R, Caan, B
Veröffentlicht in Cancer (2018)

Prospective evaluation of the cardiac safety of HER2-targeted therapies in patients with HER2-positive breast cancer and compromised heart function: the SAFE-HEaRt study

von Lynce, F., Barac, A., Geng, X., Dang, C., Yu, A. F., Smith, K. L., Gallagher, C., Pohlmann, P. R., Nunes, R., Herbolsheimer, P., Warren, R., Srichai, M. B., Hofmeyer, M., Cunningham, A., Timothee, P., Asch, F. M., Shajahan-Haq, A., Tan, M. T., Isaacs, C., Swain, S. M.
Veröffentlicht in Breast Cancer Res Treat (2019)

Management of cardiac disease in cancer patients throughout oncological treatment: ESMO consensus recommendations

von Curigliano, G., Lenihan, D., Fradley, M., Ganatra, S., Barac, A., Blaes, A., Herrmann, J., Porter, C., Lyon, A. R., Lancellotti, P., Patel, A., DeCara, J., Mitchell, J., Harrison, E., Moslehi, J., Witteles, R., Calabro, M. G., Orecchia, R., de Azambuja, E., Zamorano, J. L., Krone, R., Iakobishvili, Z., Carver, J., Armenian, S., Ky, B., Cardinale, D., Cipolla, C. M., Dent, S., Jordan, K.
Veröffentlicht in Ann Oncol (2020)